Jubilant Life Sciences announced that India Ratings and Research has re-affirmed long term issuer rating of IND AA/ Rating Watch Evolving (RWE) for Jubilant Life Sciences. The instrument-wise ratings are given below -
Fund-based Working Capital limits (Rs 550 crore) - IND AA/RWE/IND A1+/RWE
Non-fund-based Working Capital limits (Rs 840 crore) - IND A1+/RWE
Non-convertible Debentures (Rs 745 crore) - Withdrawn (paid in full)
Commercial Paper programme* (Rs 400 crore) - IND A1+/RWE
*Commercial Paper programme has been rated on a standalone basis.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
